TransThera Sciences (HKG:2617) will be included as a constituent of the Hang Seng Index Series effective Monday, March 9, according to a same-day Hong Kong bourse filing.
The clinical-stage biopharmaceutical firm has been deleted from the Hang Seng Composite SmallCap Index effective the same day.